Physician profile
Richard Michael Tangel
NPI 1184163099
$2,235.19
in general payments reported to CMS, 2019-2025
15 companies · $1,183 in 2025
The $1,183 reported for 2025 was more than what 77% of Nuclear Cardiology providers received nationally (typical 2025 total: $434).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $152 · 2021: $99.00 · 2022: $12.88 · 2023: $340 · 2024: $202 · 2025: $1,183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,708.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $311.58 | 2023-2025 | Andexxa, Wainua |
| Heartflow, INC. | $285.35 | 2025 | |
| Novartis Pharmaceuticals Corporation | $203.55 | 2022-2025 | |
| Novo Nordisk INC | $196.82 | 2025 | Ozempic, Wegovy, Rybelsus |
| Edwards Lifesciences Corporation | $162.87 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Alnylam Pharmaceuticals INC. | $147.14 | 2025 | Amvuttra |
| Astellas Pharma US INC | $99.00 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.65 | 2025 | Lifevest |
| Abbott Laboratories | $98.10 | 2023 | Gallant |
| Boston Scientific Corporation | $66.30 | 2024 | Watchman Flx |
| Amgen INC. | $48.82 | 2025 | Repatha |
| Kestra Medical Technology Services, INC. | $48.36 | 2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.00 | 2025 | Jardiance |
| Bridgebio Pharma, INC. | $18.07 | 2025 | Attruby |
| Lantheus Medical Imaging, INC. | $17.15 | 2023 | Definity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Tangel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.